Draft
-
Hospitals
MiMedx Urges FDA To Reconsider Draft Guidances During Hearing
MARIETTA, Ga., Sept. 15, 2016 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected…
Read More » -
Hospitals
FDA Updates Draft Recommendations on New 510(k) for Device Modifications
By U.S. Food and Drug Administration | August 5, 2016 The U.S. Food and Drug Administration today issued draft updated…
Read More » -
Hospitals
FDA Issues Draft Guidance on Additive Manufactured Devices
By: Carolyn LaWell Page 1 of 2 FDA recently published draft guidance on technical considerations for additive manufactured devices…
Read More »